A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer (Q37231848)
Jump to navigation
Jump to search
scientific article published on 02 July 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer |
scientific article published on 02 July 2013 |
Statements
1 reference
A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer (English)
1 reference
Catharine M L West
1 reference
Peter J Hoskin
1 reference
Guy N J Betts
1 reference
Jarrod J Homer
1 reference
Amanda Eustace
1 reference
Joely J Irlam
1 reference
Helen Denley
1 reference
Navin Mani
1 reference
Janet Taylor
1 reference
Ana M Rojas
1 reference
Johannes H A M Kaanders
1 reference
2 July 2013
1 reference
1 reference
4879-4888
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference